Publications by authors named "J P Courade"

Claim this Profile
T
The evolving landscape of Alzheimer's disease therapy: From Aβ to tau.
Jean-Philippe Courade, Henrik Zetterberg, Günter U Höglinger, Ilse Dewachter

Cell· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strain-Distinct α-Synuclein and Tau Cross-Seeding Uncovered by Correlative Approach with Optical Photothermal Infrared Sub-Micron Imaging.
Xiaoni Zhan, Wen Li, Eric Hatterer, Jean-Philippe Courade, Kristin Piché

J Am Chem Soc· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of UCB9386: A Potent, Selective, and Brain-Penetrant Nuak1 Inhibitor Suitable for Pharmacological Studies.
Karine G Poullennec, Eric Jnoff, Jan Abendroth, Naresh Bhuma, Mark Calmiano, Jean-Philippe Courade

J Med Chem· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct tau and alpha-synuclein molecular signatures in Alzheimer's disease with and without Lewy bodies and Parkinson's disease with dementia.
Bram L van der Gaag, Natasja A C Deshayes, John J P Breve, John G J M Bol, Allert J Jonker, Jean-Philippe Courade

Acta Neuropathol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of clinical failure of anti-tau and anti-synuclein antibodies in neurodegeneration using a quantitative systems pharmacology model.
Hugo Geerts, Silke Bergeler, Mike Walker, Piet H van der Graaf, Jean-Philippe Courade

Sci Rep· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis